Assessment of Serum Retinol Binding Protein 4 in Patients with Hepatocellular Carcinoma
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 10
Abstract
ABSTRACT Introduction: Retinol Binding Protein 4 (RBP4) may be indirectly involved in the induction of carcinogenesis as it was identified as a key regulator of insulin resistance in obesity and diabetes. Data about serum level of RBP4 in patients with Hepatocellular Carcinoma (HCC) are rare. The role of RBP4 in liver cirrhosis has to be further investigated as it may act as a novel biomarker for screening of HCC. Aim: To determine the value of serum RBP4 in Egyptian patients with Hepatitis C Virus (HCV) (genotype 4) related liver cirrhosis and HCC. Materials and Methods: This study was a randomised, cross-sectional, comparative study designed to measure serum RBP4 level in patients with HCV-related cirrhosis. Ninety patients were randomly recruited between October 2016 and November 2017 from the Hepatology outpatients’ clinic of Ain Shams University Hospitals and were divided into two groups as follow: Group I: 60 patients with HCV related liver cirrhosis and HCC, Group II: 30 patients with HCV related liver cirrhosis. Data were analysed with the program Statistical Package for Social Science (SPSS) under windows version 11.0.1. The statistical analysis was calculated using Student’s t-test (t), Pearson Correlation coefficient (r) test, chi-square test (c2). Results: The study revealed that patients with HCC had higher levels of serum RBP4. However, neither the number of hepatic focal lesions nor the total tumour burden had any significant correlation with serum RBP4 (p-value: 0.440 and 0.193 respectively). Serum RBP4 had also insignificant correlations with Child-pugh score, Model for End Stage Liver Disease (MELD), score Homeostasis Model of Assessment-Insulin Resistance index (HOMA-IR) and Body Mass Index (BMI). Serum RBP4 at a cut-off value >12.5 mg/mL had 73.3% sensitivity and 53.3% specificity for detection of HCC (overall accuracy=67.6%). Notably, higher values of HOMA-IR index were found among patients with HCC (mean value 2.838±1.827; range 0.400-7.300). Conclusion: RBP4 was significantly re-upregulated in patients with HCC from its reduced levels in cirrhotic patients. RBP4 has the potential to be a biomarker for the screening of HCC.
Authors and Affiliations
Yehia mohamed El Shazly, Mohamed Abd El Moghn, Reham Ezzat Al Swaff, Hany Ali Hussein, Hany Samir Rasmy, Moataz Aly Ahmad
Unfolding of a Clinically Suspected Case of Pulmonary Tuberculosis
Pulmonary nocardiosis caused by Nocardia mimics pulmonary tuberculosis in many aspects. Here, we report a case of suspected pulmonary tuberculosis turning into pulmonary nocardiosis following microbiological evaluation....
Correlation Between Sexual Satisfaction and Self-esteem and Stress in Women of Reproductive Age
ABSTRACT Introduction: Marital satisfaction is one of the factors affecting quality of life, quality of sexual relations, and interpersonal relationships. Aim: To determine the relationship between marital satisfaction...
Button Battery Ingestion: A Conundrum of Preventable Sequelae Management
ABSTRACT Foreign body ingestion is frequently encountered in infants and young children. In recent years, button batteries have become extremely common among household use. As a result of this, there has been an increase...
Significance of Serum Lactate Dehydrogenase in Childhood Acute Lymphoblastic Leukaemia
Introduction: Acute Lymphoblastic Leukaemia (ALL) is the most common childhood malignancy accounting for approximately 30% of childhood malignancies. The incidence rate of leukaemia in various parts of India varies from...
Vitamin D Levels and Associations in Indian Patients with Primary Sjögren’s Syndrome
Introduction: Vitamin D is a steroid hormone belonging to the class of secosteroids with myriad immune functions and has been implicated in aetiopathogenesis of various autoimmune diseases. Although, there have been vari...